{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:38:01Z","timestamp":1782146281176,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA138698"],"award-info":[{"award-number":["R01CA138698"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA230690"],"award-info":[{"award-number":["U01CA230690"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10552-020-01277-1","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T10:02:52Z","timestamp":1581674572000},"page":"321-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case\u2013control study"],"prefix":"10.1007","volume":"31","author":[{"given":"Yi","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Risch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda L.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Pawlish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Stroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan T.","family":"Mayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3950-4815","authenticated-orcid":false,"given":"Herbert","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"issue":"6","key":"1277_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1277_CR2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.1571","volume":"97","author":"P Pisani","year":"2002","unstructured":"Pisani P, Bray F, Parkin DM (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97(1):72\u201381","journal-title":"Int J Cancer"},{"issue":"3\u20134","key":"1277_CR3","first-page":"85","volume":"79","author":"X Ma","year":"2006","unstructured":"Ma X, Yu H (2006) Global burden of cancer. Yale J Biol Med 79(3\u20134):85\u201394","journal-title":"Yale J Biol Med"},{"issue":"2","key":"1277_CR4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87\u2013108","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1277_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2004.10.004","volume":"19","author":"KA McGlynn","year":"2005","unstructured":"McGlynn KA, London WT (2005) Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19(1):3\u201323","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"7","key":"1277_CR6","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557\u20132576","journal-title":"Gastroenterology"},{"issue":"1","key":"1277_CR7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/hep.27388","volume":"61","author":"B Njei","year":"2015","unstructured":"Njei B et al (2015) Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology 61(1):191\u2013199","journal-title":"Hepatology"},{"issue":"4","key":"1277_CR8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2016.11.020","volume":"152","author":"DL White","year":"2017","unstructured":"White DL et al (2017) Incidence of hepatocellular carcinoma in All 50 United States, from 2000 through 2012. Gastroenterology 152(4):812\u2013820 e5","journal-title":"Gastroenterology"},{"issue":"9","key":"1277_CR9","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","volume":"27","author":"SF Altekruse","year":"2009","unstructured":"Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27(9):1485\u20131491","journal-title":"J Clin Oncol"},{"issue":"11","key":"1277_CR10","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L et al (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913\u20132921","journal-title":"Cancer Res"},{"issue":"5","key":"1277_CR11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s10900-013-9703-z","volume":"38","author":"GK Singh","year":"2013","unstructured":"Singh GK, Siahpush M, Altekruse SF (2013) Time trends in liver cancer mortality, incidence, and risk factors by unemployment level and race\/ethnicity, United States, 1969\u20132011. J Community Health 38(5):926\u2013940","journal-title":"J Community Health"},{"issue":"4","key":"1277_CR12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2016.20324","volume":"317","author":"AH Mokdad","year":"2017","unstructured":"Mokdad AH et al (2017) Trends and patterns of disparities in cancer mortality among US counties, 1980\u20132014. JAMA 317(4):388\u2013406","journal-title":"JAMA"},{"issue":"10","key":"1277_CR13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/oemed-2016-104051","volume":"74","author":"KA Mundt","year":"2017","unstructured":"Mundt KA et al (2017) Quantitative estimated exposure to vinyl chloride and risk of angiosarcoma of the liver and hepatocellular cancer in the US industry-wide vinyl chloride cohort: mortality update through 2013. Occup Environ Med 74(10):709\u2013716","journal-title":"Occup Environ Med"},{"issue":"21","key":"1277_CR14","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1001\/archinte.160.21.3227","volume":"160","author":"HB El-Serag","year":"2000","unstructured":"El-Serag HB, Mason AC (2000) Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160(21):3227\u20133230","journal-title":"Arch Intern Med"},{"issue":"6","key":"1277_CR15","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.1840360609","volume":"36","author":"JA Marrero","year":"2002","unstructured":"Marrero JA et al (2002) NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36(6):1349\u20131354","journal-title":"Hepatology"},{"issue":"17","key":"1277_CR16","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE et al (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17):1625\u20131638","journal-title":"N Engl J Med"},{"issue":"2","key":"1277_CR17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2004.10.005","volume":"42","author":"JA Marrero","year":"2005","unstructured":"Marrero JA et al (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42(2):218\u2013224","journal-title":"J Hepatol"},{"issue":"37","key":"1277_CR18","doi-asserted-by":"crossref","first-page":"8294","DOI":"10.3748\/wjg.v22.i37.8294","volume":"22","author":"CR Wong","year":"2016","unstructured":"Wong CR, Nguyen MH, Lim JK (2016) Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World J Gastroenterol 22(37):8294\u20138303","journal-title":"World J Gastroenterol"},{"issue":"11\u201312","key":"1277_CR19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/apt.14342","volume":"46","author":"CR Wong","year":"2017","unstructured":"Wong CR et al (2017) Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease. Aliment Pharmacol Ther 46(11\u201312):1061\u20131069","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1277_CR20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","volume":"4","author":"HB El-Serag","year":"2006","unstructured":"El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4(3):369\u2013380","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1277_CR21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","volume":"126","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126(2):460\u2013468","journal-title":"Gastroenterology"},{"issue":"5","key":"1277_CR22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.metabol.2014.01.011","volume":"63","author":"R Karagozian","year":"2014","unstructured":"Karagozian R, Derdak Z, Baffy G (2014) Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism 63(5):607\u2013617","journal-title":"Metabolism"},{"issue":"1","key":"1277_CR23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/bjc.2012.492","volume":"108","author":"F Turati","year":"2013","unstructured":"Turati F et al (2013) Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer 108(1):222\u2013228","journal-title":"Br J Cancer"},{"issue":"7","key":"1277_CR24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10552-006-0023-9","volume":"17","author":"C Samanic","year":"2006","unstructured":"Samanic C et al (2006) Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17(7):901\u2013909","journal-title":"Cancer Causes Control"},{"issue":"1","key":"1277_CR25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.26338","volume":"131","author":"W Borena","year":"2012","unstructured":"Borena W et al (2012) Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer 131(1):193\u2013200","journal-title":"Int J Cancer"},{"issue":"3","key":"1277_CR26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.27645","volume":"132","author":"S Schlesinger","year":"2013","unstructured":"Schlesinger S et al (2013) Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer 132(3):645\u2013657","journal-title":"Int J Cancer"},{"issue":"3","key":"1277_CR27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0959-8049(94)90254-2","volume":"30A","author":"H Moller","year":"1994","unstructured":"Moller H et al (1994) Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A(3):344\u2013350","journal-title":"Eur J Cancer"},{"issue":"1","key":"1277_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1008995217664","volume":"12","author":"A Wolk","year":"2001","unstructured":"Wolk A et al (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12(1):13\u201321","journal-title":"Cancer Causes Control"},{"issue":"1","key":"1277_CR29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","volume":"123","author":"E Bugianesi","year":"2002","unstructured":"Bugianesi E et al (2002) Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123(1):134\u2013140","journal-title":"Gastroenterology"},{"issue":"5 Suppl 1","key":"1277_CR30","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1053\/j.gastro.2004.09.021","volume":"127","author":"SH Caldwell","year":"2004","unstructured":"Caldwell SH et al (2004) Obesity and hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1):S97\u2013103","journal-title":"Gastroenterology"},{"issue":"4","key":"1277_CR31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2004.02.013","volume":"40","author":"SH Caldwell","year":"2004","unstructured":"Caldwell SH, Crespo DM (2004) The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 40(4):578\u2013584","journal-title":"J Hepatol"},{"issue":"26","key":"1277_CR32","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.3748\/wjg.v13.i26.3540","volume":"13","author":"K Qureshi","year":"2007","unstructured":"Qureshi K, Abrams GA (2007) Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 13(26):3540\u20133553","journal-title":"World J Gastroenterol"},{"issue":"12","key":"1277_CR33","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","volume":"91","author":"KM Utzschneider","year":"2006","unstructured":"Utzschneider KM, Kahn SE (2006) Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91(12):4753\u20134761","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1277_CR34","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ajpath.2014.01.034","volume":"184","author":"JK Dowman","year":"2014","unstructured":"Dowman JK et al (2014) Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat\/fructose diet and sedentary lifestyle. Am J Pathol 184(5):1550\u20131561","journal-title":"Am J Pathol"},{"issue":"3","key":"1277_CR35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","volume":"65","author":"A Asgharpour","year":"2016","unstructured":"Asgharpour A et al (2016) A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J Hepatol 65(3):579\u2013588","journal-title":"J Hepatol"},{"issue":"1","key":"1277_CR36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12876-016-0477-5","volume":"16","author":"N Kishida","year":"2016","unstructured":"Kishida N et al (2016) Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine. BMC Gastroenterol 16(1):61","journal-title":"BMC Gastroenterol"},{"issue":"13","key":"1277_CR37","first-page":"5016","volume":"61","author":"S Yang","year":"2001","unstructured":"Yang S et al (2001) Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61(13):5016\u20135023","journal-title":"Cancer Res"},{"issue":"1","key":"1277_CR38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3835(03)00213-1","volume":"196","author":"M Soga","year":"2003","unstructured":"Soga M et al (2003) Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver. Cancer Lett 196(1):43\u201348","journal-title":"Cancer Lett"},{"issue":"4","key":"1277_CR39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M et al (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44(4):865\u2013873","journal-title":"Hepatology"},{"issue":"2","key":"1277_CR40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","volume":"7","author":"N Rafiq","year":"2009","unstructured":"Rafiq N et al (2009) Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 7(2):234\u2013238","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"22","key":"1277_CR41","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. JAMA 313(22):2263\u20132273","journal-title":"JAMA"},{"issue":"1","key":"1277_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z et al (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15(1):11\u201320","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"1277_CR43","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.29971","volume":"122","author":"OV Makarova-Rusher","year":"2016","unstructured":"Makarova-Rusher OV et al (2016) Population attributable fractions of risk factors for hepatocellular carcinoma in the United States. Cancer 122(11):1757\u20131765","journal-title":"Cancer"},{"issue":"5","key":"1277_CR44","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/cncr.20427","volume":"101","author":"JM Yuan","year":"2004","unstructured":"Yuan JM et al (2004) Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 101(5):1009\u20131017","journal-title":"Cancer"},{"issue":"3","key":"1277_CR45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10552-006-0105-8","volume":"18","author":"K Zhu","year":"2007","unstructured":"Zhu K et al (2007) Cigarette smoking and primary liver cancer: a population-based case-control study in US men. Cancer Causes Control 18(3):315\u2013321","journal-title":"Cancer Causes Control"},{"issue":"6","key":"1277_CR46","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/jamainternmed.2016.1548","volume":"176","author":"SC Moore","year":"2016","unstructured":"Moore SC et al (2016) Association of Leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med 176(6):816\u2013825","journal-title":"JAMA Intern Med"},{"issue":"10","key":"1277_CR47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","volume":"144","author":"GL Armstrong","year":"2006","unstructured":"Armstrong GL et al (2006) The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144(10):705\u2013714","journal-title":"Ann Intern Med"},{"issue":"2","key":"1277_CR48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jhep.2008.08.016","volume":"50","author":"MM Hassan","year":"2009","unstructured":"Hassan MM et al (2009) The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol 50(2):334\u2013341","journal-title":"J Hepatol"},{"issue":"12","key":"1277_CR49","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/1940-6207.CAPR-15-0126","volume":"8","author":"JL Petrick","year":"2015","unstructured":"Petrick JL et al (2015) NSAID use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the liver cancer pooling project. Cancer Prev Res (Phila) 8(12):1156\u20131162","journal-title":"Cancer Prev Res (Phila)"},{"issue":"23","key":"1277_CR50","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/jnci\/djs452","volume":"104","author":"VV Sahasrabuddhe","year":"2012","unstructured":"Sahasrabuddhe VV et al (2012) Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst 104(23):1808\u20131814","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-020-01277-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-020-01277-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-020-01277-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T22:52:52Z","timestamp":1613256772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-020-01277-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1007\/s10552-020-01277-1","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"19 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}